The Omnicell Blog
The pharmacy world is changing fast. The emergence of pharmacy intelligence, predictive analytics, and increasing demand for a complete end-to-end solution means healthcare leaders must innovate to meet both new medication management challenges (COVID-19) and old (diversion, patient safety, and rising costs).
The Omnicell Blog is the leading source for pharmacy information on emerging trends, successful best practices, and ideas and insights to help pharmacies digitally transform to lower cost and improve patient safety.
Time for Congress to Break the Contract Pharmacy Logjam
Safety net providers, which are losing hundreds of millions of dollars each year in needed savings, don’t have the luxury of time. Neither do the patients that rely on 340B providers for affordable medicine and healthcare services. It’s time for Congress to take action.
The Infrastructure Bills: Implications for Bipartisanship and Common-Sense Healthcare Legislation
How Congress handles two mammoth infrastructure bills will likely set the political tone in Washington through the 2022 midterm elections, and possibly the remainder of President Joe Biden’s term.
Summer 2021 – Transforming Pharmacy Through Innovation and Superior Customer Experience
Our Summer 2021 Release delivers enhancements across our entire portfolio designed to improve efficiency, expand automation, and enhance intelligence, supported through a superior customer experience, driving maximum value sooner for your technology investment.
Be the Change: Leveraging Intelligence to Enhance Medication Management
COVID-19 heightened the focus on how technology can drive change, especially in Pharmacy, where the opportunity to eliminate manual tasks and improve medication supply chain visibility can and will improve quality, reduce costs, and increase human efficiency. Here are a few trends we’re seeing at HIMSS21 this week in Las Vegas.
Legislation that 340B Providers and the Drug Industry Can Both Embrace
Imagine if there was a way to resolve two of the most intractable challenges in the 340B program in one fell swoop: one that has a significant impact on the financial health of 340B providers, and another that affects the pharmaceutical industry’s bottom line? It may be hard to imagine, but there is now a bill in Congress that can be welcomed by both the 340B covered entity community and the drug industry.
FDS Amplicare Acquisition Will Help Support EnlivenHealth’s Retail Pharmacy Transformation Strategy
The combination of EnlivenHealth and FDS Amplicare will help us advance and accelerate our mission to build and orchestrate the most advanced digital engagement technologies designed to help retail pharmacies and health plans keep their patients and members healthy, while strengthening business results.
Pursuing the Vision of Autonomous Pharmacy
One area of opportunity to enhance pharmacy practice is the implementation of technology. The status quo is failing both practitioners and patients. How are leading health systems assessing their medication management strategy to identify opportunities for improvement?
Personalizing Our Path to the Autonomous Pharmacy
Pharmacy transformations are happening every day. As leaders, we need to identify the challenges that need to be addressed in order to not only deliver improved patient care, but to elevate clinician satisfaction, and optimize pharmacy performance.
Autonomous Pharmacy Drives Efficient Hospitals, Safer Patients
By connecting medication inventory and leveraging the data pulled from that technology, there is a huge opportunity to reduce error, improve efficiency, control costs, ensure compliance and, ultimately, enhance patient care and safety.
The views and opinions expressed in this blog are those of the authors and do not necessarily reflect the official policy or position of any other agency, organization, employer or company. Assumptions made in the analysis are not reflective of the position of any entity other than the author(s). These views are always subject to change, revision, and rethinking at any time and may not be held in perpetuity.